otilonium bromide

Complete salt match

Require evidence for both the otilonium component and bromide, rather than relying on a name or organic-ion signal alone.

1. Which structural identifier explicitly represents both otilonium and bromide? definition
2. Which analytical results establish the organic identity and counterion composition? measurement

Substance versus product

Attach external records only after checking whether they describe the salt, cation or a formulated medicine.

1. Does each linked identifier denote the complete bromide salt? boundary
2. What source supports mapping an alternative spelling or supplier name to this entry? provenance

Usable salt content

Keep mass assay separate from chromatographic purity and distinguish salt-equivalent from cation-equivalent quantities.

1. Is the reported percentage a mass assay or chromatographic area percentage, and on what moisture basis? measurement
2. Is the requested concentration expressed as complete otilonium bromide or otilonium cation equivalents? boundary

Qualified material

Evaluate related substances, residual solvents and applicable contaminants using documented methods and acceptance criteria.

1. Which otilonium-related impurities are identified, quantified or left unresolved by the analytical method? measurement
2. Which certificate, specification and qualification records justify using this lot for the proposed purpose? action

Form and thermal events

Record crystal-form evidence, water or solvent inclusion and measured thermal events for the material examined.

1. What measurements establish the solid form and any associated water or solvent? measurement
2. Does a reported thermal event represent melting, desolvation, a transition or decomposition? boundary

Conditioned preparation

Supplier guidance reports solvent-specific solubility and separate limits for aqueous preparations; retain its product scope. [Preparation guidance](https://cdn.caymanchem.com/cdn/insert/29907.pdf)

1. At the intended pH, solvent composition and temperature, what dissolved concentration is demonstrated? measurement
2. What stability evidence supports the storage interval for this solid lot or prepared solution? provenance
3. What precipitation or analytical change requires rejecting or requalifying the preparation? action

Multiple functional actions

A study using human cultured colonic smooth-muscle cells and rat colonic strips reports inhibition of calcium-channel, muscarinic and tachykininergic responses. [Primary study](https://pubmed.ncbi.nlm.nih.gov/23941257/)

1. Which target, stimulus, species and preparation support each attributed action? provenance
2. What concentration-response endpoint was measured, and how was dissolved exposure verified? measurement
3. Does the experiment establish direct target interaction or only inhibition of a downstream response? boundary

Local versus systemic exposure

Experimental literature describes poor absorption and gastrointestinally concentrated exposure; quantitative transfer to a particular human use requires matching evidence. [Primary pharmacology study](https://pmc.ncbi.nlm.nih.gov/articles/PMC2867415/)

1. Which route, species, formulation and sampling method support an absorption or tissue-exposure claim? provenance
2. Are measured concentrations total, unbound, plasma or tissue values, and are they comparable to the assay concentrations? measurement
3. What additional clinical evidence is needed before a mechanistic result supports a therapeutic claim? boundary

Documented hazard controls

Require an applicable SDS and distinguish an absent exposure limit from a demonstrated safe exposure.

1. Which dated SDS and jurisdiction support the assigned GHS classification for this material? provenance
2. Is an occupational exposure limit established, or is its status unverified? measurement
3. Which documented controls govern weighing, solution preparation, spills and disposal? action

Grade and authorisation

A supplier's research material is explicitly restricted to research use; that record cannot establish pharmaceutical suitability. [Supplier use restriction](https://cdn.caymanchem.com/cdn/insert/29907.pdf)

1. What evidence qualifies this specific lot for research, pharmaceutical manufacture or another stated activity? action
2. Which jurisdiction-specific authorisation belongs to a finished medicine rather than to this substance record? boundary

Check these first

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these check these first hold for the sense of otilonium bromide this model covers, and on what evidence? provenance

Identifiers and schemes

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these identifiers and schemes hold for the sense of otilonium bromide this model covers, and on what evidence? provenance

Real-world use

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these real-world use hold for the sense of otilonium bromide this model covers, and on what evidence? provenance

Typical measurements

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these typical measurements hold for the sense of otilonium bromide this model covers, and on what evidence? provenance

Failure modes and hazards

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these failure modes and hazards hold for the sense of otilonium bromide this model covers, and on what evidence? provenance

Regional variation

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these regional variation hold for the sense of otilonium bromide this model covers, and on what evidence? provenance

Neighbouring kinds and how to tell them apart

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these neighbouring kinds and how to tell them apart hold for the sense of otilonium bromide this model covers, and on what evidence? provenance